BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  G1 Therapeutics to Provide Fourth Quarter and Full Year 2021 Financial Results and Business Update on February 23, 2022

  G1 Therapeutics, Inc. will host a webcast and conference call to provide a corporate and financial update for the fourth quarter and full year 2021 on Wednesday, February 23, 2022 at 8:30 a.m. ET.

  February 9, 2022

   · 

  1 min read
• Pharm Country

  Race, Socioeconomic Factors Skew Skin Cancer Survival, Feinstein Institutes Study Finds

  Acral lentiginous melanoma is a form of skin cancer that disproportionately affects minority groups.

  February 9, 2022

   · 

  3 min read
• Deals

  Imagia Cybernetics & Canexia Health Merge to Supercharge Precision Oncology Accessibility

  Imagia Cybernetics , an AI-healthcare company that accelerates oncology solutions generated from real world data, today announced its merger with Canexia Health.

  February 9, 2022

   · 

  4 min read
• Archwire Market Size, Share, Growth, Trends, Revenue, Key Players and Forecast Till 2027

  The report provides details about market size, market restraints, drivers, challenges, growth opportunities, and top companies in the market.

  February 9, 2022

   · 

  6 min read
• Skin Barrier Applicators Market Size, Share, Growth, Sales Revenue and Key Drivers Analysis Research Report by 2028

  The report provides details about market size, market restraints, drivers, challenges, growth opportunities, and top companies in the market.

  February 9, 2022

   · 

  6 min read
• Drug Development

  Dompé announces first patient enrolled in Phase 3 trial of cenegermin in patients with severe Sjögren’s-related dry eye disease

  Dompé farmaceutici S.p.A. and Dompé U.S. Inc. (collectively Dompé) announced today that the first patient has been enrolled in its Phase 3 clinical trial to evaluate the efficacy and safety of cenegermin.

  February 9, 2022

   · 

  8 min read
• CMC Pharmaceuticals Announces New Advisory Board

  CMC Pharmaceuticals, a provider of drug product development services to the pharmaceutical and biotechnology industries, announces the formation of an Advisory Board.

  February 9, 2022

   · 

  4 min read
• Biotech Bay

  eFFECTOR Therapeutics to Present at 2022 BIO CEO & Investor Conference

  eFFECTOR Therapeutics, a biopharmaceutical company focused on pioneering the development of selective translation regulator inhibitors for the treatment of cancer, announced that the Company will present and host 1x1 meetings at the 2022 BIO CEO & Investor Conference.

  February 9, 2022

   · 

  2 min read
• Biotech Bay

  Berkeley Lights to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

  Berkeley Lights, Inc., a leader in digital cell biology, announced the Company will participate in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held virtually from February 15 - 17, 2022.

  February 9, 2022

   · 

  2 min read
• Drug Development

  Affimed Announces Publication of Preclinical Data Demonstrating Cytotoxic Potency and Efficacy of NK Cells Precomplexed with Innate Cell Engagers after Freezing & Thawing

  Affimed N.V., a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced the publication of pre-clinical data demonstrating the cytotoxic potency and efficacy of NK cells precomplexed with ICE® molecules after one cycle of cryopreservation.

  February 9, 2022

   · 

  4 min read